InvestorsHub Logo

DankStar

11/03/18 2:47 PM

#19521 RE: stervc #19520

Great to have you here stervc and thanks for your insightful perspective. It is much appreciated.

JohnnyBlaze

11/03/18 9:37 PM

#19522 RE: stervc #19520

Lots to like here, would guess they will be current in the next 30 days. Can’t wait to see the new revenue streams!!

FTR

01/05/19 12:15 PM

#20610 RE: stervc #19520

Sterve,
I came across MGON..
Thanks for your DD. I think you’re right about the potential.
I think I will start with a small position in MGON this week.

GLTY
FTR

GreenGro

01/23/19 2:47 PM

#20641 RE: stervc #19520

Anticipating updates to Nevada SOS in next week or two.


JPerdue2

02/13/19 8:42 AM

#20682 RE: stervc #19520

Looks very promising

JohnnyBlaze

02/26/19 10:11 PM

#20734 RE: stervc #19520

$MGON 's (.005) true value... $.078 (15 bagger eminent?!!!)
Seems like we should see some big movement in the short term, lots happening, lots to like, and a great share structure, oh yeah big revenues & PROFITS!!! $MGON

MGON News & Confirmed .078 EBITDA Valuation...

This is very solid news for MGON that justifies a value of .078 per share based on EBITDA as explained below:
Quote:

https://ih.advfn.com/p.php?pid=nmona&article=78592380
Houston, Texas, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Publicly-held Megola, Inc. (OTC Pink: MGON) is pleased to announce current status of revenues and future direction of sales distributions into the United States and Canadian CBD (Cannabidiol) markets. Acordy President Francisco Baez states: “For 2018, the Company is rapidly approaching 2 million euros ($2.4 million US Dollars) in revenues. This reflects an increase of over 300% compared with the same nine month period of 2017. Pretax profits for the nine months ending 9-30-2018 came in at €490,524 (approximately USD$ 585,000) representing nearly a 200 % increase over 2017. With Megola introducing CBD products and CBD infused olive oil into the U.S. and Canada, we are poised for substantial growth in 2019”.


Below is a Gross Valuation Based on EBITDA:

Gross Income ÷ Outstanding Shares (OS) = Earnings Per Share (EPS)
EPS x Price to Earnings (PE) Ratio = MGON Share Price Valuation

$585,000 per 9 months = $65,000 Per Month Per Year
$65,000 x 12 = $780,000 Gross Profit Per Year

$780,000 ÷ 196,095,060 Shares (MGON OS) = .0039 EPS

.0039 EPS x 20 PE Ratio = .078 MGON Share Price Valuation EBITDA

I used 20 as what I believe is a fair and conservative Price to Earnings (PE) Ratio as the growth rate for the Marijuana Industry.

Also, this does not take into account any future growth that is planned by the company which leads me to believe that MGON is significantly undervalued. More info about Acordy is below:

jdcpa1

02/28/19 6:50 AM

#20763 RE: stervc #19520

Stervc, are those financial #s MGONs or Acordy's which is not part of MGON. Very confusing how that public statement was written and its a big difference who they are speaking about..Even the Cannabis harvest. Is that owned by MGON or Acordy?? Thanks in advance..